Breast Lesion Localization Methods Market

Breast Lesion Localization Methods Market worth $877.9 million by 2020

The report "Breast Lesion Localization Methods Market - Comparative Analysis, Field Force Analysis, Business Models, End User Preference Survey (Selection Criteria, Qualitative Analysis of Replacement Trend), Competitive Product Portfolio and Strategic Consolidation", analyzes and studies breast lesion localization methods in terms of replacement trends, competitor portfolio, and selection criteria for adopting breast lesion localization methods from an end-user perspective. It also provides a detailed overview of the major drivers, restraints, opportunities, challenges, current market trends, and strategic consolidations impacting the market, along with estimates and forecasts of revenue.

Browse 7 market data Tables and 20 Figures spread through 55 Slides and in-depth TOC on "Breast Lesion Localization Methods Market"
https://www.marketsandmarkets.com/Market-Reports/breast-lesion-localization-methods-market-35768623.html
Early buyers will receive 10% customization on reports.

The overall market for breast lesion localization methods is estimated to reach $877.9 million by 2020 from $445.9 million in 2015, at a CAGR of 14.5% from 2015 to 2020.

The overall market for breast lesion localization methods is expected to witness rapid growth owing to the increasing number of breast cancer surgeries and implementation of favorable reimbursement guidelines. Furthermore, the rising demand for better quality care, and growing awareness amongst patients about breast cancer screening are the other major factors driving the breast lesion localization methods market. On the other hand, market growth of breast lesion localization methods will be restrained by the uncertainty in regulatory approval procedures as a result of the risks associated with breast lesion localization devices. However, force field analysis of the market depicts that the driving forces outweigh the restraining forces.

Based on the type of localization devices, the market of breast lesion localization methods is segmented into wire localization, radioisotope localization (radioactive seed localization, radio occult lesion localization), magnetic tracers, and others. Among these segments, wire localization is the major focus of players as it is an established technique in the market. Also, the comparative analysis of four major types of localization methods shows that wire localization is still the gold standard for breast localization, resulting in continued adoption of this technique among end users. However, according to the replacement trends studied in all geographies, most end users are expected to switch from wire localization to radio-guided localization methods (especially radioactive seed localization) in the near future.

This report contains detailed analysis of end user preferences for the adoption of different breast lesion localization methods. The research findings cited in the report encapsulate the important selection criteria for breast lesion localization methods from an end-user perspective. It analysis the importance given to a particular criteria by end users during the selection of a breast lesion localization method; some of the important selection criteria include detection and success rate, re-excision rate, cost, mean localization time, effectiveness, safety, ease of use, and mean operating time.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
Email: sales@marketsandmarkets.com

Report Code
MD 4236
Published ON
Apr, 2016
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Breast Lesion Localization Methods Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved